SIC 8071 – Medical Laboratories
Valuation | |
---|---|
Market Cap ($M) | 31.80 |
Enterprise Value ($M) | 33.07 |
Book Value ($M) | -1.46 |
Book Value / Share | -0.01 |
Price / Book | -21.76 |
NCAV ($M) | -1.46 |
NCAV / Share | -0.01 |
Price / NCAV | -21.76 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | n/a |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.07 |
Current Ratio | 0.07 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 0.11 |
Assets | 0.11 |
Liabilities | 1.57 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -1.45 |
Net Income | -2.46 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -0.65 |
Cash from Investing | 0.00 |
Cash from Financing | 0.24 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
100 | 100 | 100.00 | |
(click for more detail) |
Similar Companies | |
---|---|
FCHS – First Choice Healthcare Solutions, Inc. | GNLKQ – GeneLink, Inc. |
HALB – Halberd Corporation | MEDD – Medical Imaging Corp. |
NVTAQ – Invitae Corporation |
Financial data and stock pages provided by
Fintel.io